Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 5Ovarian Neoplasms 3Small Cell Lung Carcinoma 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Fallopian Tube Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Rectal Diseases 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Colonic Diseases 1Carcinoma, Hepatocellular 1

Interventions

Etoposide 13Carboplatin 13Filgrastim 12Peripheral Blood Stem Cell Transplantation 11Ifosfamide 10Cisplatin 10Paclitaxel 8Cyclophosphamide 6Bleomycin 6Thiotepa 3Radiotherapy 3sargramostim 2pegfilgrastim 2etoposide phosphate 2aldesleukin 2Temozolomide 2Methylprednisolone 2Immunologic Techniques 2Flow Cytometry 2Amplified Fragment Length Polymorphism Analysis 2Alemtuzumab 2sabarubicin 1ixabepilone 1guadecitabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1Vincristine 1Vinblastine 1Topotecan 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Testicular Germ Cell Tumor × guadecitabine × Clear all
NCT02429466 2020-09-23

Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors

Indiana University

Phase 1 Completed
14 enrolled
Genitourinary

Testicular Germ Cell Tumor, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡